Anders N. Pedersen

Copenhagen University Hospital — Denmark

Biochemistry, Genetics and Molecular Biology · Life Sciences

27h-index3.1kcitations48works9.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(13), Galectins and Cancer Biology(13), Advanced Radiotherapy Techniques(12), Peptidase Inhibition and Analysis(10), Protease and Inhibitor Mechanisms(9)

Publications48 total

Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver
European Journal of Pharmacology·2024· 10 cited
Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon Resonance
International Journal of Molecular Sciences·2024· 1 citedOpen Access
Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung Cancer
Journal of Medicinal Chemistry·2024· 26 citedOpen Access
Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon Resonance
Preprints.org·2024· 2 citedOpen Access
Benefit of respiratory gating in the Danish Breast Cancer Group partial breast irradiation trial
Radiotherapy and Oncology·2024· 7 citedOpen Access
Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1
Frontiers in Immunology·2023· 29 citedOpen Access
Evaluating the affinity and kinetics of small molecule glycomimetics for human and mouse galectin-3 using surface plasmon resonance
SLAS DISCOVERY·2023· 9 citedOpen Access
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants
Cancer Chemotherapy and Pharmacology·2023· 36 citedOpen Access
Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial
Radiotherapy and Oncology·2022· 39 citedOpen Access
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease
Journal of Medicinal Chemistry·2022· 88 citedOpen Access
Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia
Radiation Oncology·2022· 13 citedOpen Access
Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation
Frontiers in Pharmacology·2022· 28 citedOpen Access
Partial Breast Irradiation Versus Whole Breast Irradiation for Early Breast Cancer Patients in a Randomized Phase III Trial: The Danish Breast Cancer Group Partial Breast Irradiation Trial
Journal of Clinical Oncology·2022· 74 citedOpen Access
The effect of the galectin-3 inhibitor GB0139 on acute lung injury
Zenodo (CERN European Organization for Nuclear Research)·2022Open Access
Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study
Journal of Clinical Oncology·2022· 76 cited
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis
European Respiratory Journal·2020· 205 citedOpen Access
No changes in myocardial perfusion following radiation therapy of left-sided breast cancer: A positron emission tomography study
Journal of Nuclear Cardiology·2019· 11 cited
An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade
Cancer Research·2019· 138 citedOpen Access
Treatment with a highly selective Galectin-3 Inhibitor, GAL-200-10, reduces both pathological corneal neovascularization and fibrosis
Investigative Ophthalmology & Visual Science·2018Open Access
Joint Estimation of Cardiac Toxicity and Recurrence Risks After Comprehensive Nodal Photon Versus Proton Therapy for Breast Cancer
International Journal of Radiation Oncology*Biology*Physics·2016· 48 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Ulf J. Nilsson(13), Hakon Leffler(11), Robert J. Slack(11), Fredrik R. Zetterberg(11), Nils Brünner(10), Lena Specht(9), Alison C. MacKinnon(9), Stine Korreman(8), Hans Schambye(8), Ross W. Stephens(8), Hans Jørgen Nielsen(8), Håkan Nyström(7), James A. Roper(7), Birgitte Vrou Offersen(6), Martin Berg(6), Mirjana Josipović(6), Gunilla Høyer‐Hansen(6), Ingelise Jensen(5), Mette Holck Nielsen(5), Keld Danø(5)